Micropos Medical (NGM:MPOS) - Share price, News & Analysis

MPOS fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

MPOS Stock Overview

Micropos Medical AB (publ), a medical device company, develops technologies that enhance the precision in radiotherapy of cancer.

Risk Analysis

Makes less than USD$1m in revenue (SEK3M)

Shareholders have been diluted in the past year

Does not have a meaningful market cap (SEK358M)

Micropos Medical Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Micropos Medical
Historical stock prices
Current Share Price	kr2.88
52 Week High	kr3.99
52 Week Low	kr1.92
Beta	1.08
1 Month Change	-5.88%
3 Month Change	2.86%
1 Year Change	7.06%
3 Year Change	234.88%
5 Year Change	63.64%
Change since IPO	-63.31%

Recent News & Updates

May 11

We're Not Very Worried About Micropos Medical's (NGM:MPOS) Cash Burn Rate

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Shareholder Returns

	MPOS	SE Medical Equipment	SE Market
7D	-4.0%	5.6%	-1.3%
1Y	7.1%	-35.0%	-23.6%

Return vs Industry: MPOS exceeded the Swedish Medical Equipment industry which returned -35% over the past year.

Return vs Market: MPOS exceeded the Swedish Market which returned -23.6% over the past year.

Price Volatility

Is MPOS's price volatile compared to industry and market?
MPOS volatility
MPOS Average Weekly Movement	9.0%
Medical Equipment Industry Average Movement	8.5%
Market Average Movement	7.4%
10% most volatile stocks in SE Market	12.2%
10% least volatile stocks in SE Market	4.7%

Stable Share Price: MPOS is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: MPOS's weekly volatility (9%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2003	6	Thomas Lindstrom	https://www.micropos.se

Micropos Medical AB (publ), a medical device company, develops technologies that enhance the precision in radiotherapy of cancer. Its products include RayPilot receiving system, a sensor plate; RayPilot transmitter for positioning, patient identification, and in situ dosimetry; and RayPilot software for use in patient identification, patient set up, ROI positioning, and in situ dosimetry in the control room. Micropos Medical AB (publ) was founded in 2003 and is based in Gothenburg, Sweden.

Micropos Medical Fundamentals Summary

How do Micropos Medical's earnings and revenue compare to its market cap?
MPOS fundamental statistics
Market Cap	kr358.27m
Earnings (TTM)	-kr15.52m
Revenue (TTM)	kr2.64m

136.0x

P/S Ratio

-23.1x

P/E Ratio

Is MPOS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
MPOS income statement (TTM)
Revenue	kr2.64m
Cost of Revenue	kr922.00k
Gross Profit	kr1.71m
Other Expenses	kr17.24m
Earnings	-kr15.52m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	-0.12
Gross Margin	65.01%
Net Profit Margin	-589.18%
Debt/Equity Ratio	2.7%

How did MPOS perform over the long term?

See historical performance and comparison

We’ve recently updated our valuation analysis.

Valuation

Is MPOS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MPOS?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for MPOS. This is calculated by dividing MPOS's market cap by their current preferred multiple.
What is MPOS's n/a Ratio?
n/a Ratio	0x
n/a	n/a
Market Cap	kr358.27m

MPOS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	129.7x
Enterprise Value/EBITDA	-25.3x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does MPOS's PB Ratio compare to its peers?

MPOS PB Ratio vs Peers

The above table shows the PB ratio for MPOS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	PB	Estimated Growth	Market Cap
Peer Average	7.2x

Price-To-Book vs Peers: MPOS is expensive based on its Price-To-Book Ratio (18x) compared to the peer average (7.2x).

Price to Earnings Ratio vs Industry

How does MPOS's PE Ratio compare vs other companies in the SE Medical Equipment Industry?

Price-To-Book vs Industry: MPOS is expensive based on its Price-To-Book Ratio (18x) compared to the Swedish Medical Equipment industry average (3.6x)

Price to Book Ratio vs Fair Ratio

What is MPOS's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MPOS PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	18x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate MPOS's Price-To-Book Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of MPOS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate MPOS's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate MPOS's fair value for valuation analysis.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MPOS's PEG Ratio to determine if it is good value.

Discover undervalued companies

Future Growth

How is Micropos Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

19.6%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Micropos Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

Examine Micropos Medical's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.

Past Performance

How has Micropos Medical performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

3.4%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: MPOS is currently unprofitable.

Growing Profit Margin: MPOS is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: MPOS is unprofitable, but has reduced losses over the past 5 years at a rate of 3.4% per year.

Accelerating Growth: Unable to compare MPOS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MPOS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).

Return on Equity

High ROE: MPOS has a negative Return on Equity (-78.03%), as it is currently unprofitable.

Discover strong past performing companies

Financial Health

How is Micropos Medical's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Stable Cash Runway
Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: MPOS's short term assets (SEK21.0M) exceed its short term liabilities (SEK6.2M).

Long Term Liabilities: MPOS's short term assets (SEK21.0M) exceed its long term liabilities (SEK930.0K).

Debt to Equity History and Analysis

Debt Level: MPOS has more cash than its total debt.

Reducing Debt: MPOS's debt to equity ratio has reduced from 3% to 2.7% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MPOS has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: MPOS has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 2.8% each year.

Discover healthy companies

Dividend

What is Micropos Medical current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate MPOS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MPOS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MPOS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MPOS's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MPOS has not reported any payouts.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

kr1m

CEO Compensation

CEO

Thomas Lindstrom (55 yo)

2yrs

Tenure

kr1,046,844

Compensation

Mr. Thomas Lindstrom has been Chief Executive Officer at Micropos Medical AB (publ) since June 2020. He has a long background in Sales, marketing and organisation development within Medtech industry since...

CEO Compensation Analysis

Compensation vs Market: Thomas's total compensation ($USD103.38K) is below average for companies of similar size in the Swedish market ($USD233.45K).

Compensation vs Earnings: Insufficient data to compare Thomas's compensation with company performance.

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.6%.

Data	Last Updated (UTC time)
Company Analysis	2022/06/26 00:00
End of Day Share Price	2022/06/23 00:00
Earnings	2022/03/31
Annual Earnings	2021/12/31